A single-judge bench of Delhi high court had allowed Dr Reddy’s to continue manufacturing and exporting semaglutide to non-patent jurisdictions, while restraining domestic sales until the patent expires in March 2026.
A single-judge bench of Delhi high court had allowed Dr Reddy’s to continue manufacturing and exporting semaglutide to non-patent jurisdictions, while restraining domestic sales until the patent expires in March 2026. by Soban News (international And National News)
